Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic ...

How could Trump’s tariffs affect prices, availability at the pharmacy? “That additional 10 percent tariff is going to have a ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

"Our manufacturers sell at an extremely low price ... that shut down production lines. In some cases, drug manufacturers stopped making a drug. Because so many U.S. generic drug companies purchase ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...

CSPC Pharma is now facing a steep drop in its full-year profits, hit by price controls for its signature products under China's national healthcare system.

Relocating generic drug production to the US is not an overnight ... Generic drugs, with their relatively low prices, provide essential medical protection for numerous Americans.

Drugmakers have begun to roll-out their generic versions of ... The three launches have crashed the price by 80-90 per cent. BI sells its global $8 billion-grossing drug under the name Jardiance ...

Canada’s tiered pricing framework for generics dictates that injectable drugs such as Ozempic be sold at 35 per cent of the branded product’s list price if there are three or more generic ...

JP Morgan upgraded Amneal to Overweight, raising its price target to $12 ... extended-release capsules. The generic drug was launched in September. J.P. Morgan analyst Chris Schott reports ...